Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Aug;42(8):2106-8.
doi: 10.1128/AAC.42.8.2106.

Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada

C Gaudreau  1 , H Gilbert
Affiliations

Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada

C Gaudreau et al. Antimicrob Agents Chemother. 1998 Aug.

Abstract

The antimicrobial resistance of 158 Campylobacter jejuni strains isolated from humans in Quebec, Canada, from 1995 to 1997 was compared to the resistance of 47 and 86 strains of C. jejuni isolated in 1985 and 1986 and in 1992 and 1993, respectively. Of the 291 C. jejuni strains tested, no strain was resistant to erythromycin. Compared to the C. jejuni strains isolated in 1985 and 1986, the C. jejuni strains isolated in 1992 and 1993 were more resistant to tetracycline (40.7 versus 19.1%, respectively; P = 0. 01) but not to nalidixic acid or ciprofloxacin (P > 0.05). Compared to the C. jejuni strains isolated in 1992 and 1993 and in 1985 and 1986, the C. jejuni strains isolated from 1995 to 1997 were more resistant to tetracycline (55.7% versus 40.7 and 19.1%, respectively; P = 0.03 and P < 0.001, respectively) to nalidixic acid (13.9% versus 4.7 and 0%, respectively; P = 0.02 and P = 0.007, respectively), and to ciprofloxacin (12.7% versus 3.5 and 0%, respectively; P = 0.02 and P = 0.009, respectively).

PubMed Disclaimer

References

    1. Blaser M J. Campylobacter and related species. In: Mandell G L, Doug J E, Dolin R, editors. Principles and practice in infectious diseases. 4th ed. New York, N.Y: Churchill Livingstone; 1995. pp. 1948–1956.
    1. Endtz H P, Ruijs G J, van Klingeren B, Jansen W H, van der Reyden T, Mouton R P. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother. 1991;27:199–208. - PubMed
    1. Gaudreau C, Gilbert H. Comparison of disk diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. J Antimicrob Chemother. 1997;39:707–712. - PubMed
    1. Gootz T D, Martin B A. Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrob Agents Chemother. 1991;35:840–845. - PMC - PubMed
    1. Harnett N, McLeod S, Au Yong Y, Hewitt C, Vearncombe M, Krishnan C. Quinolone resistance in clinical strains of Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother. 1995;36:269–270. - PubMed

LinkOut - more resources